KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Gross Margin (2016 - 2025)

Historic Gross Margin for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to 61.83%.

  • Idexx Laboratories' Gross Margin rose 7300.0% to 61.83% in Q3 2025 from the same period last year, while for Sep 2025 it was 61.72%, marking a year-over-year increase of 10000.0%. This contributed to the annual value of 61.04% for FY2024, which is 12200.0% up from last year.
  • According to the latest figures from Q3 2025, Idexx Laboratories' Gross Margin is 61.83%, which was up 7300.0% from 62.62% recorded in Q2 2025.
  • Idexx Laboratories' Gross Margin's 5-year high stood at 62.62% during Q2 2025, with a 5-year trough of 56.97% in Q4 2021.
  • Moreover, its 5-year median value for Gross Margin was 60.19% (2022), whereas its average is 60.18%.
  • Its Gross Margin has fluctuated over the past 5 years, first soared by 31200bps in 2021, then tumbled by -9100bps in 2022.
  • Idexx Laboratories' Gross Margin (Quarter) stood at 56.97% in 2021, then grew by 3bps to 58.53% in 2022, then fell by 0bps to 58.36% in 2023, then increased by 2bps to 59.8% in 2024, then rose by 3bps to 61.83% in 2025.
  • Its Gross Margin was 61.83% in Q3 2025, compared to 62.62% in Q2 2025 and 62.44% in Q1 2025.